Sept 26 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX ANNOUNCES RESUBMISSION OF RIZAPORT® NEW DRUG APPLICATION
* INTELGENX TECHNOLOGIES - RESUBMITTED ITS 505(B)(2) NEW DRUG APPLICATION FOR RIZAPORT VERSAFILM FOR TREATMENT OF ACUTE MIGRAINES TO U.S. FDA